Other Aliphatic rings

• 

  5-methyl-3-(pyrrolidin-3-yl)-1,2,4-oxadiazole hydrochloride

  AD1746982126176-78-990%
• 

  trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate

  AD1746881443979-21-290%
• 

  N-[2-(1,4-diazepan-1-yl)-2-oxoethyl]acetamide hydrochloride

  AD1746752059938-23-590%
• 

  3-(tert-butoxy)azetidine

  AD1746521147530-63-990%
• 

  4-(pyrrolidin-3-ylmethyl)morpholine

  AD174584933704-68-890%
• 

  N,N-dimethylmorpholine-2-carboxamide hydrochloride

  AD1744981361115-06-190%
• 

  rac-{[(3aR,6aS)-hexahydro-1H-furo[3,4-c]pyrrol-3a-yl]methyl}(ethyl)methylamine

  AD1741902165348-99-090%
• 

  3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one

  AD1741821780867-93-790%
• 

  tert-butyl N-[2-(piperazin-1-yl)ethyl]carbamate

  AD174135140447-78-590%
• 

  3-cycloheptylazetidine hydrochloride

  AD1740602138513-86-590%
• 

  (azetidin-3-yl)methanesulfonamide hydrochloride

  AD1740522413904-31-990%
• 

  1-(azetidin-3-yl)-4-(2-methoxyethyl)piperazine trihydrochloride

  AD1740492411291-02-490%
• 

  [(3-methoxyoxolan-3-yl)methyl](methyl)amine

  AD1740141564700-21-590%
• 

  azetidine-2-carboxamide

  AD173962130973-78-390%
• 

  1-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]piperazine dihydrochloride

  AD1739481269151-73-690%
• 

  1-(piperazin-1-yl)-2-(1H-1,2,3,4-tetrazol-1-yl)ethan-1-one

  AD173834923183-58-890%
• 

  4-[2-(pyrrolidin-3-yloxy)ethyl]morpholine dihydrochloride

  AD1738221394040-42-690%
• 

  1-[1-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]piperazine

  AD1737351247780-89-790%
• 

  rac-3-tert-butyl 4-ethyl (3R,4R)-pyrrolidine-3,4-dicarboxylate, trans

  AD1737342375250-89-690%
• 

  dimethyl[2-(morpholin-2-yl)ethyl]amine

  AD173695933752-37-590%